NASDAQ: CLPT - ClearPoint Neuro, Inc.

Yield per half year: +197.17%
Sector: Healthcare

Share chart ClearPoint Neuro, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain. It has license and collaboration agreements with Clinical Laserthermia Systems AB, Koninklijke Philips N.V.

more details
, Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

EBITDA -0.0043
EV/EBITDA -15.19
IPO date 2020-02-12
ISIN US18507C1036
Industry Health Care Equipment & Supplies
P/BV 15.06
P/S 6.16
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 0.0112
Сайт https://www.clearpointneuro.com
Цена ао 6.54
Число акций ао 0.02461 млрд
Change price per day: -4.43% (16.48)
Change price per week: +1.32% (15.545)
Change price per month: +30.06% (12.11)
Change price per 3 month: +40.75% (11.19)
Change price per half year: +197.17% (5.3)
Change price per year: +131.96% (6.79)
Change price per 3 year: +39.38% (11.3)
Change price per 5 year: +324.53% (3.71)
Change price per 10 year: 0% (15.75)
Change price per year to date: +7.66% (14.63)
All parameters

Underestimation

Title Value Grade
P/S 6.74 1
P/BV 7.62 1
P/E 0 0
EV/EBITDA -7.25 0
Total: 3.5

Efficiency

Title Value Grade
ROA, % -51.78 0
ROE, % -104.33 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.4942 10
Total: 8

Growth impulse

Title Value Grade
Yield Revenue, % 113.88 10
Yield Ebitda, % 388.12 10
Yield EPS, % 81.58 9
Total: 9.8
More

Institutions Volume Share, %
Blackrock Inc. 1470056 5.43
Vanguard Group Inc 1308694 4.83
Geode Capital Management, LLC 489155 1.81
Taylor Frigon Capital Management LLC 352606 1.3
State Street Corporation 348898 1.29
Brown Advisory Inc. 333395 1.23
Cahill Wealth Management, LLC 232263 0.86
CM Management, LLC 200000 0.74
Northern Trust Corporation 197885 0.73
Lane Generational LLC 174291 0.64

ETF Share, % Profitability for 1 year, % Dividends, %
iShares Neuroscience and Healthcare ETF 0.55389 19.72 0.03
iShares Micro-Cap ETF 0.08253 11.9 1.54048



Head Job title Payment Year of birth
Mr. Joseph Michael Burnett President, CEO & Director 803.12k 1977 (48 years)
Mr. Jeremy Stigall Chief Business Officer 392.66k 1984 (41 year)
Mr. Mazin Sabra Chief Operating Officer N/A 1981 (44 years)
Ms. Ellisa Cholapranee General Counsel & Secretary N/A
Ms. Jacqueline Keller Vice President of Marketing N/A
Mr. Danilo D'Alessandro Chief Financial Officer 1986 (39 years)

Address: United States, Solana Beach. CA, 120 S. Sierra Avenue - open in Google maps, open in Yandex maps
Website: https://www.clearpointneuro.com